Alaska Airlines, Seattle's largest international carrier, is adding Athens and Paris to its growing global network.Alaska, the first airline to ever connect Seattle and Athens, will become the only airline offering nonstop service between the West Coast and Greece's capital when flights begin in May 2027.When service to Paris launches next spring, Alaska will become the first oneworld airline to provide nonstop service between the West Coast and Paris, one of the region's most in-demand transatlantic markets.The hometown airline is teaming up with Seattle's star quarterback, Sam Darnold, for a multi-season campaign that celebrates new turf and Seattle hometown pride. 

Alaska Airlines, Seattle's largest international carrier, is adding Athens and Paris to its growing global network.Alaska, the first airline to ever connect Seattle and Athens, will become the only airline offering nonstop service between the West Coast and Greece's capital when flights begin in May 2027.When service to Paris launches next spring, Alaska will become the first oneworld airline to provide nonstop service between the West Coast and Paris, one of the region's most in-demand transatlantic markets.The hometown airline is teaming up with Seattle's star quarterback, Sam Darnold, for a multi-season campaign that celebrates new turf and Seattle hometown pride. 

If your idea of the perfect beach vacation includes more than lazing in the sun, these destinations deserve a spot on your bucket list. From hidden coves and historic landmarks to wildlife encounters and cooking classes, they offer experiences you’ll remember long after your tan fades.

NEW YORK and ATHENS, Greece, June 13, 2026 /PRNewswire/ -- Kos Biotechnology Partners ("Kos"), a global life sciences investment firm bridging the US biopharma ecosystem with Europe, today announced the third closing of its inaugural global life sciences fund, bringing total capital commitments to $123M (€106M). Following its initial launch in December 2025, the fund has secured backing from a syndicate of prominent institutional investors—including lead investor Hellenic Development Bank of Investments (HDBI)—and global family offices.

NEW YORK and ATHENS, Greece, June 13, 2026 /PRNewswire/ -- Kos Biotechnology Partners ("Kos"), a global life sciences investment firm bridging the US biopharma ecosystem with Europe, today announced the third closing of its inaugural global life sciences fund, bringing total capital commitments to $123M (€106M). Following its initial launch in December 2025, the fund has secured backing from a syndicate of prominent institutional investors—including lead investor Hellenic Development Bank of Investments (HDBI)—and global family offices.